Portfolio Lab

Elevance Health, Inc.

  • Stock
  • Ticker ELV
  • ISIN US0367521038
  • NYSE

Health care · Health care services · USA

$394.48 +1.11%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Elevance Health, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ELVGlobal equities (VT)

$10,000 grew to $32,956. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −50.4% in 08/2025, measured from the peak in 09/2024. The old peak has not been reached again yet.

1-year return
+28.1%
5-year return p.a.
+0.4%
10-year return p.a.
+12.7%
Volatility p.a.
27.8%
Largest decline
−50.4%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue45,44248,89149,77650,71149,74750,18150,47451,429
Gross profit39,43043,90844,48345,33144,22544,71844,98245,789
Operating income6733,1702,4251,2953092,0861,7631,269
EBITDA1,3793,5432,8051,6827152,4402,1291,632
Net income4182,1831,7431,1895471,7641,4631,365
Earnings per share1.879.617.725.322.548.006.716.27
Balance sheet
Total assets116,889119,717121,938122,749121,494125,827126,438127,801
Liabilities75,46377,09778,08778,66777,46881,78581,41683,007
Equity41,31542,50343,72243,95343,88243,90244,88344,681
Cash8,2887,5008,5608,7139,4919,65710,23210,348
Long-term debt29,21828,11028,17831,17330,79730,76830,66930,382
Cash flow
Operating cash flow7061,0172,0541,135844,3321,9131,267
Capital expenditure-322-196-267-360-293-235-287-267
Free cash flow3848211,787775-2094,0971,6261,000

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2017 at +58.7%, weakest 2024 at −20.7%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
21 Oct 2026$6.27
15 Jul 2026$6.71
22 Apr 2026$8.00
6 Feb 2026$2.54
21 Oct 2025$5.32
17 Jul 2025$7.72
22 Apr 2025$9.61
20 Feb 2025$1.87
17 Oct 2024$4.36
17 Jul 2024$9.85
18 Apr 2024$9.59
21 Feb 2024$3.66

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€77bn
Market cap in trading currency
$85.2bn
Enterprise value
$80.3bn
P/E
16.8
P/S
0.42
P/B
1.91
EV/Sales
0.40
EV/EBITDA
11.6
Earnings yield
6.0%
FCF yield
7.6%

Results (last four quarters)

Revenue
$202bn
Gross profit
$180bn
EBITDA
$6.92bn
Net income
$5.14bn
Earnings per share
$23.52
Revenue per share
$934.16
Revenue growth
+1.4%
Earnings growth
+14.8%

Profitability

Gross margin
89.0%
Operating margin
2.7%
Net margin
2.5%
Return on equity
11.6%
Return on assets
4.0%

Balance sheet and cash flow

Cash
$35.7bn
Cash per share
$165.21
Financial debt
$30.8bn
Debt/equity %
69
Current ratio
1.47
Book value per share
$206.80
Operating cash flow
$7.60bn
Free cash flow
$6.51bn

Dividend

Dividend yield
1.74%
Dividend (12 months)
$6.87
Yield (12 months)
1.74%
Payout ratio
29%
Ex-dividend date
10 Sep 2026

Shares and trading

Shares outstanding
216m
Volume
2.03m
Avg. volume 3 months
1.22m
Relative volume
1.6

Price and technicals

Price
$394.48
1 day
+1.1%
52-week high
$446.28
52-week low
$280.74
Distance to 52-week high
−11.6%
Distance to 52-week low
+40.5%
Distance to 50-day line
−5.1%
Distance to 200-day line
+4.5%
RSI (14)
39
Volatility 1M
42.3%

Performance

1 week
−8.2%
1 month
−11.4%
3 months
−2.0%
6 months
−0.1%
YTD
+12.5%
1 year
+24.7%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ELV performed since 11/2016?

$10,000 grew to $32,956 by 20 Nov 2026, which is +12.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ELV?

Volatility was 27.8% per year, measured on monthly returns. The largest decline from a peak was −50.4%, with the low in 08/2025.

How does ELV compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ELV returned +12.7% at 27.8%. The correlation of monthly returns was 0.46; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Elevance Health, Inc. (ELV): Return and risk | Portfolio Lab